Google
Trusted Resources: News & Events
Latest announcements and gatherings
Global HOPE Initiative Plans $100M Pediatric Hematology-Oncology Treatment Network in Africa
The Bristol-Myers Squibb Foundation, Texas Children’s Cancer and Hematology Centers and Baylor College of Medicine plan to jointly create a treatment network for children with cancer and blood diseases in three sub-Saharan African countries.
The $100 million initiative, Global HOPE (Hematology-Oncology Pediatric Excellence), aims to build the medical capacity needed to diagnose and properly treat these conditions in Botswana, Malawi and Uganda — whose combined population of 54 million is served by only five pediatric oncologists.
The partnership will recruit physicians, nurses and other healthcare professionals worldwide to train about 4,800 local healthcare providers to treat kids with cancer and blood disorders such as sickle cell disease (SCD), which is common throughout much of Africa.
+myBinderRelated Content
-
Piedmont Health Services and Sickle Cell Agency 7th Annual Sickle Cell Walk/Run – VirtualOur walk/run will be virtual this year d...
-
Sickle Cell and Thalassaemia Support Group of Barking, Dagenham and HaveringWe are the Sickle Cell and Thalassaemia ...
-
IASCNAPA Sickle Cell Disease Conference: Treating the Whole PersonDate: April 14-15, 2021 Place: Online/V...
-
2019-2021 ASH Clinical Practice Guidelines on Sickle Cell Disease: What You Should KnowThe American Society of Hematology (ASH)...
-
Emerging opportunities in sickle cell disease cure, treatment and pain managementIn support of City of Hope’s recent CI...
-
Why do blood types matter? – Natalie S. Hodgehttps://www.youtube.com/watch?v=xfZhb6lm...
-
Piedmont Health Services and Sickle Cell Agency 11th Annual Sickle Cell Charity RideJoin us for a fun and exciting motorcycl...
To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences. More Information
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.
Powered by
Support for this site is provided by
This platform is made possible through a partnership with the Sickle Cell Disease Association of America, Inc. (SCDAA) and its member organizations. SCDAA's mission is to advocate for people affected by sickle cell conditions and empower community-based organizations to maximize quality of life and raise public consciousness while advancing the search for a universal cure.